Quintrio
Home

Stock overview

Baird Medical Investment Holdings Ltd Ordinary Share

BDMD

Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.

Last trade $0.0903
Day change -$0.0162 (-15.21%)
Day range $0.0895 – $0.094
Volume 3,508,496
Market cap $3M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for BDMD.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for BDMD.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED

Baird Medical announced a strategic distribution partnership with ALLIS MED to serve as Korea License Holder and exclusive distributor of its microwave ablation products in South Korea following regulatory certification. The partnership marks another milestone in Baird Medical's global expansion strategy, with the company having entered multiple new markets in 2026 including Argentina, Egypt, Pakistan, and Vietnam, while also advancing its IRE-based products and AI-powered robotic ablation system.

GlobeNewswire Inc.

Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology

Baird Medical announced medical device registrations in Vietnam and preliminary regulatory approval in Egypt for its microwave ablation technology. The company received Class C registration certificates in Vietnam for multiple MWA products including needles and generators, while the Egyptian Drug Authority granted preliminary approval for its BD-GT Microwave Ablation System. These milestones support the company's international expansion strategy beyond the U.S. and China markets.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.